Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(7R,8R,9R)-2,3,10-trimethyl-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridine-7,8-diol
-
(7R,8R,9R)-2,3-dimethyl-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridine-7,8-diol
high-affinity K+-competitive inhibitor
(8-[(2-ethyl-6-methylbenzyl)amino]-2,3-dimethylimidazo[1,2-a]pyrazin-6-yl)methanol
-
-
(R)-(+)-[(2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy]acetic acid
-
a K+-Cl- cotransport, KCC, inhibitor, inhibits the enzyme in intact apical canalicular membranes, not in lealy membranes, via inhibition of the K+-Cl- cotransport
1,3,5,6-tetrahydroxy-2-(3-hydroxy-3-methylbutyl)-xanthone
-
a xanthone isolated from Calophyllum brasiliense leaves
1-(2',6'-dimethylbiphenyl-3-yl)-4-methylpiperazine
-
-
1-(2',6'-dimethylbiphenyl-3-yl)-N-methylmethanamine
-
-
1-hydroxy-3,5,6-tri-O-acetyl-2(3,3-dimethyl-allyl)-xanthone
-
a xanthone isolated from Calophyllum brasiliense leaves
2-(2',6'-diethylbiphenyl-3-yl)-4,5-dimethyl-1H-imidazole
-
-
2-(2',6'-dimethylbiphenyl-2-yl)-4,5-dimethyl-1H-imidazole
-
-
2-(2',6'-dimethylbiphenyl-3-yl)-1,4,5-trimethyl-1H-imidazole
-
-
2-(2',6'-dimethylbiphenyl-3-yl)-1-methyl-1H-imidazole
-
-
2-(2',6'-dimethylbiphenyl-3-yl)-1-propyl-1H-imidazole
-
-
2-(2',6'-dimethylbiphenyl-3-yl)-1H-imidazole
-
-
2-(2',6'-dimethylbiphenyl-3-yl)-4,5-diethyl-1H-imidazole
-
-
2-(2',6'-dimethylbiphenyl-3-yl)-4,5-dimethyl-1H-imidazole
-
-
2-(2',6'-dimethylbiphenyl-3-yl)-5-phenyl-1H-imidazole
-
-
2-(2',6'-dimethylbiphenyl-3-yl)pyridin-4-amine
-
-
2-(2-methoxy-2',6'-dimethylbiphenyl-3-yl)-4,5-dimethyl-1H-imidazole
-
-
2-(4-ethoxy-2',6'-dimethylbiphenyl-3-yl)-4,5-dimethyl-1H-imidazole
-
-
2-(4-methoxy-2',6'-dimethylbiphenyl-3-yl)-4,5-dimethyl-1-propyl-1H-imidazole
-
-
2-(4-methoxy-2',6'-dimethylbiphenyl-3-yl)-4,5-dimethyl-1H-imidazole
-
-
2-(6-methoxy-2',6'-dimethylbiphenyl-3-yl)-4,5-dimethyl-1H-imidazole
-
-
2-(biphenyl-3-yl)-4,5-dimethyl-1H-imidazole
-
-
2-(biphenyl-4-yl)-4,5-dimethyl-1H-imidazole
-
-
2-Methoxy-2,4-diphenyl-3-dihydrofuranone
2-methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile
2-phenyl-6,7-dihydrobenzofuran-4(5H)-one oxime
-
-
2-[(4-[4-[4-(azidomethyl)phenoxy]butoxy]-3-methylpyridin-2-yl)methanesulfinyl]-1H-benzimidazole
inhibits ATPase activity by approximately 50% at 0.01 mM
2-[4-(2,6-dimethylphenyl)furan-2-yl]-4,5-dimethyl-1H-imidazole
-
-
2-[4-(2,6-dimethylphenyl)thiophen-2-yl]-4,5-dimethyl-1H-imidazole
-
-
2-[4-(benzyloxy)-2',6'-dimethylbiphenyl-3-yl]-4,5-dimethyl-1H-imidazole
-
-
2-[4-(difluoromethoxy)-2',6'-dimethylbiphenyl-3-yl]-4,5-dimethyl-1H-imidazole
-
-
2-[5-(2,6-dimethylphenyl)-1-benzofuran-7-yl]-4,5-dimethyl-1H-imidazole
-
-
2-[5-(2,6-dimethylphenyl)-2,3-dihydro-1-benzofuran-7-yl]-4,5-dimethyl-1H-imidazole
-
-
2-[5-(2,6-dimethylphenyl)furan-2-yl]-4,5-dimethyl-1H-imidazole
-
-
2-[5-(2,6-dimethylphenyl)thiophen-2-yl]-4,5-dimethyl-1H-imidazole
-
-
2-{[3-(4,5-dimethyl-1H-imidazol-2-yl)-2',6'-dimethylbiphenyl-4-yl]oxy}acetamide
-
-
3'-(4,5-dimethyl-1H-imidazol-2-yl)-3-methylbiphenyl-4-thiol
-
-
3-(4,5-dimethyl-1H-imidazol-2-yl)-2',6'-dimethylbiphenyl-4-ol
-
-
3-(4-oxo-3,4-dihydroquinazolin-2-yl)-N'-(3,4,5-trihydroxybenzylidene)propanehydrazide
-
-
3-(4-oxo-3,4-dihydroquinazolin-2-yl)-N'-(3,4,5trimethoxybenzylidene)propanehydrazide
-
-
3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanehydrazide
-
-
3-({[3-(4,5-dimethyl-1H-imidazol-2-yl)-2',6'-dimethylbiphenyl-4-yl]oxy}methyl)pyridine
-
-
4,5-dimethyl-2-(2',4,5,6'-tetramethylbiphenyl-3-yl)-1H-imidazole
-
-
-
4,5-dimethyl-2-(2',6,6'-trimethylbiphenyl-3-yl)-1H-imidazole
-
-
4,5-dimethyl-2-(2'-methylbiphenyl-3-yl)-1H-imidazole
-
-
4,5-dimethyl-2-[3-(2-phenylethenyl)phenyl]-1H-imidazole
-
-
4,5-dimethyl-2-[3-(2-phenylethyl)phenyl]-1H-imidazole
-
-
4-(2',6'-dimethylbiphenyl-3-yl)-1,2-dimethyl-1H-imidazole
-
-
4-(4-oxo-3,4-dihydroquinazolin-2-yl)-N'(3,4,5trimethoxybenzylidene)butanehydrazide
-
-
4-(4-oxo-3,4-dihydroquinazolin-2-yl)-N'-(3,4,5-trihydroxybenzylidene)butanehydrazide
-
-
4-(4-oxo-3,4-dihydroquinazolin-2-yl)butanehydrazide
-
-
4-([2-[(1H-benzimidazole-2-sulfinyl)methyl]-3-methylpyridin-4-yl]oxy)butyl [4-(1,2,4,5-tetrazin-3-yl)phenyl]acetate
inhibits ATPase activity by approximately 50% at 0.01 mM
5,5'-dithiobis(2-nitrobenzoic acid)
5-(2',6'-dimethylbiphenyl-3-yl)-1-methyl-1H-imidazole
-
-
6-desoxyjacareubin
-
a xanthone isolated from Calophyllum brasiliense leaves
8-(benzyloxy)-2-methylimidazo[1,2-a]pyridine
-
8-[(2-ethyl-6-methylbenzyl)amino]-2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide
-
-
8-[(2-ethyl-6-methylbenzyl)amino]-N,2,3-trimethylimidazo[1,2-a]pyrazine-6-carboxamide
-
-
8-[(2-ethyl-6-methylbenzyl)amino]-N,N,2,3-tetramethylimidazo[1,2-a]pyrazine-6-carboxamide
-
-
8-[(2-ethyl-6-methylbenzyl)amino]-N-(2-hydroxyethyl)-2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide
-
-
8-[(2-ethyl-6-methylbenzyl)amino]-N-(2-methoxyethyl)-2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide
-
-
8-[[(1S,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxamide
-
-
8-[[(1S,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-N,2,3-trimethylimidazo[1,2-a]pyridine-6-carboxamide
-
-
8-[[(1S,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-N,N,2,3-tetramethylimidazo[1,2-a]pyridine-6-carboxamide
-
-
8-[[(1S,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-N-(1-methoxyethyl)-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxamide
-
-
8-[[(1S,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]oxy]-N,N,2,3-tetramethylimidazo[1,2-a]pyridine-6-carboxamide
-
-
8-[[(1S,2S)-2-hydroxy-7-methoxy-2,3-dihydro-1H-inden-1-yl]oxy]-N,N,2,3-tetramethylimidazo[1,2-a]pyridine-6-carboxamide
-
-
8-[[(1S,2S)-2-hydroxy-7-methyl-2,3-dihydro-1H-inden-1-yl]oxy]-N,N,2,3-tetramethylimidazo[1,2-a]pyridine-6-carboxamide
-
-
ATP
-
ATP concentrations over 5 mM induce H+/K+-ATPase activity inhibition, suggesting the existence of ATP-regulatory sites
beryllium fluoride
irreversible inhibition by the fluorinated phosphate analogue, activity is not restored by divalent cations, e.g. Mg2+. Electronmicrospoic structure of BeF-bound H+,K+-ATPase at 8 A resolution, and structural comparison of H+,K+-ATPase in the E2BeF and E2AlF states, overview
BMT-1
-
i.e. 2-(1H-benzimidazol-2-yl)-4,5,6,7-tetrahydro-2H-indazol-3-ol
BYK73
i.e. (7R,8R,9R)-2,3,10-trimethyl-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridine-7,8-diol
BYK99
i.e. (7R,8R,9R)-2,3-dimethyl-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridine-7,8-diol, high-affinity K+-competitive inhibitor
clotrimazole
-
molecular mechanism of the inhibitory effect is studied by steady-state fluorescence experiments with the electrochromic styryl dye RH421
digoxigenin
-
inhibition of mutant D312E/S319G/A778P/I795L/F802C, not of the wild-type enzyme
dihydro-ouabain
-
inhibition of mutant D312E/S319G/A778P/I795L/F802C, not of the wild-type enzyme
ethyl 2-ethoxyquinoline-1(2H)-carboxylate
Fluorescein 5'-isothiocyanate
-
fluorescein 5'-isothiocyanate modified enzyme has 0.5-1.5% residual ATPase activity compared to the unmodified enzyme
ginger hydrolysed phenolic fraction
-
of ginger, Zingiber officinale, rhizome, constituted by cinnamic (48%), 4-coumaric (34%) and caffeic (6%) acids as major phenolic acids, as potent inhibitors of gastric cell proton potassium ATPase activity and Helicobacter pylori growth, exhibiting strong antioxidant potency, overview
-
ginger-free phenolic fraction
-
the fraction is constituted by syringic (38%), gallic (18%) and cinnamic (14%) acids, as potent inhibitors of gastric cell proton potassium ATPase activity and Helicobacter pylori growth, exhibiting strong antioxidant potency, overview
-
jacareubin
-
a xanthone isolated from Calophyllum brasiliense leaves
K+
-
activates, required. But in the presence of 200m M KCl, ion binding sites are more than 99% saturated with K+. The enzyme activity under this condition is near zero
lonchocarpin
-
a chalcone isolated from Lonchocarpus guatemalensis roots
magnesium fluoride
reversible inhibition by the fluorinated phosphate analogue, activity is restored by divalent cations, e.g. Mg2+
mammea A/BA
-
a coumarin isolated from Calophyllum brasiliense leaves
mammea C/OA
-
a coumarin isolated from Calophyllum brasiliense leaves
methyl {[3-(4,5-dimethyl-1H-imidazol-2-yl)-2',6'-dimethylbiphenyl-4-yl]oxy}acetate
-
-
minimiflorin
-
a flavonoid isolated from Lonchocarpus oaxacensis roots
Mn2+
-
in presence of Mg2+
mundulin
-
a flavonoid isolated from Lonchocarpus oaxacensis roots
N'-(2,3-dibromobenzyliden)-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propane hydrazide
-
-
N'-(2,3-dibromobenzyliden)-4-(4-oxo-3,4-dihydroquinazolin-2-yl)butanehydrazide
-
-
N'-(2,4-dichlorobenzyliden)-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propane hydrazide
-
-
N'-(2,4-dichlorobenzylidene)-4-(4-oxo-3,4-dihydroquinazolin-2-yl)butanehydrazide
-
-
N'-(2,4-difluorobenzyliden)-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propane hydrazide
-
-
N'-(2,4-difluorobenzylidene)-4-(4-oxo-3,4-dihydroquinazolin-2-yl)butanehydrazide
-
-
N'-(2-chloro-6-fluorobenzylidene)-3-(4-oxo-3,4-dihydroquinazolin-2-yl)butane hydrazide
-
-
N'-(2-chloro-6-fluorobenzylidene)-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propane hydrazide
-
-
N'-(2-fluoro-5-nitrobenzyliden)-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propane hydrazide
-
-
N'-(2-fluoro-5-nitrobenzyliden)-4-(4-oxo-3,4-dihydroquinazolin-2-yl)butanehydrazide
-
-
N'-(3,4-dihydroxy-5-methoxybenzylidene)-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanehydrazide
-
-
N'-(3,4-dihydroxy-5-methoxybenzylidene)-4-(4-oxo-3,4-dihydroquinazolin-2-yl)butanehydrazide
-
-
N'-(4-chlorobenzylidene)-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanehydrazide
-
-
N'-(4-chlorobenzylidene)-4-(4-oxo-3,4-dihydroquinazolin-2-yl)butanehydrazide
-
-
N'-(4-hydroxy-3-methoxybenzylidene)-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanehydrazide
-
-
N'-(4-hydroxy-3-methoxybenzylidene)-4-(4-oxo-3,4-dihydroquinazolin-2-yl) butanehydrazide
-
-
N'-(4-hydroxybenzylidene)-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanehydrazide
-
-
N'-(4-hydroxybenzylidene)-4-(4-oxo-3,4-dihydroquinazolin-2-yl)butanehydrazide
-
-
N'-(4-methoxybenzylidene)-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanehydrazide
-
-
N'-(4-methoxybenzylidene)-4-(4-oxo-3,4-dihydroquinazolin-2-yl)butanehydrazide
-
-
N'-(4-nitrobenzylidene)-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanehydrazide
-
-
N'-(4-nitrobenzylidene)-4-(4-oxo-3,4-dihydroquinazolin-2-yl)butanehydrazide
-
-
N'-benzylidene-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanehydrazide
-
-
N'-benzylidene-4-(4-oxo-3,4-dihydroquinazolin-2-yl)butanehydrazide
-
-
N,N'-dicyclohexylcarbodiimide
N-(2,6-dimethylbenzyl)-3-(4,5-dimethyl-1H-imidazol-2-yl)aniline
-
-
N-(2-ethyl-6-methylbenzyl)-2,3-dimethyl-6-(pyrrolidin-1-ylcarbonyl)imidazo[1,2-a]pyrazin-8-amine
-
-
N-(2-ethyl-6-methylbenzyl)-6-(methoxymethyl)-2,3-dimethylimidazo[1,2-a]pyrazin-8-amine
-
-
N-(4-fluorobenzylidene)-3-(4-oxo-3,4-dihydroquinazolin-2-yl)butane hydrazide
-
-
N-(4-fluorobenzylidene)-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propane hydrazide
-
-
N-[3-(4,5-dimethyl-1H-imidazol-2-yl)phenyl]-2,6-dimethylaniline
-
-
N-[3-(4,5-dimethyl-1H-imidazol-2-yl)phenyl]benzamide
-
-
ouabagenin
-
inhibition of mutant D312E/S319G/A778P/I795L/F802C, not of the wild-type enzyme
p-chloromercuribenzene sulfonate
potato galactan polysaccharide
-
potent inhibitory activity with an IC50 value of 0.42 mg/ml in vitro
-
SCH-CN-
i.e. 8-(benzyloxy)-2-methylimidazo[1,2-a]pyridine
SCH-Me-
i.e. [8-(benzyloxy)imidazo[1,2-a]pyridin-3-yl]acetonitrile
strophanthidin
-
inhibition of mutant D312E/S319G/A778P/I795L/F802C, not of the wild-type enzyme
trimethyltin chloride
-
i.e. TMT, trimethyltin chloride directly inhibits the activity of H+/K+-ATPases in renal intercalated cells reducing urine K+ reabsorption and inducing hypokalemia. It increases potassium leakage from the kidney, raises urine pH, and inhibits H+/K+-ATPase activity both in vitro and in vivo. In toxicated rats, H+/K+-ATPase activity is positively correlated with the decrease of plasma K+ and blood pH but is negatively correlated with the increase of urine K+ and urine pH, while trimethyltin chloride does not change the expression of H+/K+-ATPase protein and mRNA
[(dihydroindenyl)oxy]acetic acid
-
DIOA
[8-(benzyloxy)-2-methylimidazo[1,2-a]pyridin-3-yl]acetonitrile
-
[8-(benzyloxy)imidazo[1,2-a]pyridin-3-yl]acetonitrile
-
2-Methoxy-2,4-diphenyl-3-dihydrofuranone
-
-
2-Methoxy-2,4-diphenyl-3-dihydrofuranone
-
-
2-methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile
-
i.e. SCH28080
2-methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile
-
i.e. SCH28080
2-methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile
-
-
2-methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile
-
i.e. SCH28080
2-methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile
-
i.e. SCH28080
2-methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile
-
i.e. SCH28080
5,5'-dithiobis(2-nitrobenzoic acid)
-
-
5,5'-dithiobis(2-nitrobenzoic acid)
-
-
aluminum fluoride
reversible inhibition by the fluorinated phosphate analogue, activity is restored by divalent cations, e.g. Mg2+. Structural comparison of H+,K+-ATPase in the E2BeF and E2AlF states, overview
Ba2+
-
is a known inhibitor of K+ channels, and completely inhibits the whole-cell currents
Butanedione
-
-
BYK36399
-
-
Ca2+
-
2 mM, complete inhibition
diethyldicarbonate
-
-
digoxin
-
-
digoxin
-
inhibition of mutant D312E/S319G/A778P/I795L/F802C, not of the wild-type enzyme
Dipicrylamine
-
-
esomeprazole
-
-
ethyl 2-ethoxyquinoline-1(2H)-carboxylate
-
-
ethyl 2-ethoxyquinoline-1(2H)-carboxylate
-
-
F-
-
-
lansoprazole
-
-
lansoprazole
-
IC50 value of 0.0193 mg/ml
luteolin
-
-
N,N'-dicyclohexylcarbodiimide
-
-
N,N'-dicyclohexylcarbodiimide
-
-
N,N'-dicyclohexylcarbodiimide
-
-
N-methyl-BYK36399
-
-
Na+
-
above 100 mM, 60-70% inhibition
NEM
-
-
oligomycin
-
increases the phosphorylation of the enzyme and the sensitivity of the phosphorylated intermediate to AD inhibiting the conversion of E1P to E2P
Omeprazole
-
-
Omeprazole
-
inhibits HKalpha1
Omeprazole
-
acid-activated, irreversible
Omeprazole
-
binding at Cys813 and Cys892 is reversible both in vivo and in vitro
Omeprazole
-
inhibits HKalpha1
Omeprazole
-
pH-dependent inhibition
Omeprazole
-
no effect in the presence of K+ alone or NH4+. Inhibitory action can be fully reversed by addition of beta-mercaptoethanol
Ouabain
-
-
Ouabain
-
inhibits HKalpha2, but not HKalpha1
Ouabain
-
K+ exhibits strong antagonism with the inhibitor
Ouabain
-
blocks Rb+ uptake
Ouabain
-
inhibits Rb+ uptake in a dose-dependent manner
Ouabain
-
inhibits HKalpha2, but not HKalpha1
Ouabain
-
inhibition of mutant D312E/S319G/A778P/I795L/F802C, not of the wild-type enzyme
oubain
-
-
oubain
-
binding affinity of wild-type is 2000fold lower than that of mutated enzyme in NH4+-stimulated Sf9 cells
p-chloromercuribenzene sulfonate
-
-
p-chloromercuribenzene sulfonate
-
-
pantoprazole
-
-
pantoprazole
-
binding at Cys822 is irreversible
rabeprazole
-
-
rabeprazole
complete inhibition at 0.1 mM
SCH 28080
-
inhibits the NH4+-stimulated activity
SCH 28080
-
inhibits HKalpha1, but not HKalpha2
SCH 28080
-
inhibits HKalpha1, but not HKalpha2
SCH28080
-
-
SCH28080
-
potent competitive inhibitor
SCH28080
-
i.e., 2-methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile
SCH28080
IC50: 0.00041 for wild-type enzyme
SCH28080
-
K+ exhibits strong antagonism with the inhibitor
SCH28080
strictly competitive with respect to K+ or NH4+, binds near the M5-6 luminal loop, preventing K+ access to the ion binding domain
SCH28080
low concentrations decrease phosphorylation levels of mutants with an E2 preference, whereas it hardly changes with E1-prefering mutants, even increases phosphorylation levels in the E820Q mutant
SCH28080
-
H+/K+-ATPase inhibitor
SCH28080
a K+-competitive inhibitor, SCH28080 is specific for both E2 and E2P conformations
SCH28080
-
completely blocks enzyme activity
SCH28080
specific H+,K+-ATPase inhibitor
SCH28080
i.e., 2-methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile
SCH28080
i.e. 2-methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile
SCH28080
-
i.e., 2-methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile
timoprazole
-
-
Trypsin
-
-
-
Trypsin
-
limited proteolysis, determination of peptide fragment sequences, overview
-
vanadate
-
-
vanadate
interacts specifically with the E2 conformational state
vanadate
-
potent inhibition of catalytic and transport activities
Zn2+
-
-
additional information
-
inhibitor binding and inhibition kinetics
-
additional information
-
no inhibition by SCH-28080 and bafilomycin-A
-
additional information
-
H+/K+-ATPase inhibition does not affect Cx43 expression in chicken
-
additional information
-
almost resistant to digoxigenin and ouabagenin
-
additional information
-
inhibitor binding and inhibition kinetics
-
additional information
-
chlorofom extract of Baccharis illinita flowers inhibits the H+-K+-ATPase and gastric acid secretion in rabbit stomach, no inhibition by naringenin and kaempferol
-
additional information
-
inhibitor binding and inhibition kinetics
-
additional information
-
determination of minimal inhibitory concentration, MIC, values
-
additional information
-
chlorofom extract of Baccharis illinita flowers inhibits the H+-K+-ATPase and gastric acid secretion in rat stomach
-
additional information
-
inhibitor binding and inhibition kinetics
-
additional information
-
wild-type non-gastric H,K-ATPase shows a very low affinity for ouabain
-
additional information
-
addition of trimethyltin chloride alters the whole-cell current and opens K+ channels in renal cells, overview
-
additional information
-
development of 6-substituted imidazo[1,2-a]pyrazines inhibitors of the gastric H+/K+-ATPase, no inhibition by 8-[(2-ethyl-6-methylbenzyl)amino]-2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide
-
additional information
-
development of indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase, overview
-
additional information
-
inhibitor binding and inhibition kinetics
-
additional information
-
pharmacophore modelling against known imidazopyridine and azaindole templates for detection and development of structure-based enzyme inhibitors, overview
-
additional information
mechanism, by which divalent cations, e.g. Mg2+, reactivate the fluorinated phosphate analogue-inhibited H+,K+-ATPase. Mg2+ interacts with the outside of the vesicles, namely the cytoplasmic side of the enzyme, overview. Prevention of the Mg2+-induced reactivation by K+ binding. The magnitude of the Mg2+-induced reactivation is highly pH dependent, whereas the BeF-inhibited enzyme is not affected
-